tanaproget

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2015
01220052015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Herein a new (11) C radiolabelling strategy for the fast and efficient synthesis of thioureas and related derivatives using the… (More)
  • table 1
  • figure 1
Is this relevant?
2010
2010
The level of progesterone receptors (PRs) in breast tumors can be used to guide the selection of endocrine therapies for breast… (More)
Is this relevant?
2010
2010
The progesterone receptor (PR) is estrogen regulated, and PR levels in breast tumors can be used to predict the success of… (More)
Is this relevant?
2006
2006
CONTEXT Endometriosis, the growth of endometrial tissue outside the uterus, is principally an estrogen-dependent disease. In… (More)
Is this relevant?
2006
2006
Tanaproget is a first-in-class nonsteroidal progesterone receptor agonist that is being investigated for use in contraception. A… (More)
Is this relevant?
2006
2006
We have identified mRNA markers of estradiol and progesterone action in the mouse mammary gland and uterus to establish an in… (More)
Is this relevant?
2006
2006
We report a docking and comparative molecular similarity indices analysis (CoMSIA) study of progesterone receptor (PR) ligands… (More)
Is this relevant?
2006
2006
OBJECTIVE This study aimed to evaluate the pharmacokinetics, pharmacodynamics and safety of the nonsteroidal progesterone… (More)
Is this relevant?
2005
2005
Progesterone receptor (PR) agonists have several important applications in women's health, such as in oral contraception and post… (More)
  • table 1
  • table 2
Is this relevant?
2005
2005
Tanaproget represents a potential first-in-class nonsteroidal PR agonist for contraception with improved safety and side effect… (More)
Is this relevant?